SUMITOMO PHARMA CO. LTD. revenue for the last year amounted to 3.86 B EUR, the most of which — 3.55 B EUR — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 3.86 B EUR. The greatest contribution to the revenue figure was made by North America — last year it brought SUMITOMO PHARMA CO. LTD. 2.28 B EUR, and the year before that — 2.37 B EUR.